AbbVie (ABBV) said Sunday that patients taking GLP-1 weight-loss medications reported improved satisfaction with their facial appearance following cosmetic treatments in two clinical studies conducted by its Allergan Aesthetics division.

The findings, presented at the American Society for Dermatologic Surgery’s annual